Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease
Background/AimsThe clinical use of measuring infliximab (IFX) trough levels (TLs) and antibodies against IFX (ATIs) in patients with pediatric inflammatory bowel disease (IBD) remains unclear. We propose measuring these variables to create individual IFX treatment strategies for patients with pediat...
| 發表在: | Gut and Liver |
|---|---|
| Main Authors: | , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Gastroenterology Council for Gut and Liver
2017-01-01
|
| 主題: | |
| 在線閱讀: | http://gutnliver.org/journal/view.html?doi=10.5009/gnl16041 |